$HROW 3 SEC Filings

Filed On	Filing
02 Feb 2026	Form 3: Sullivan Patrick William, CHIEF COMMERCIAL OFFICER
10 Oct 2025	Form 3: Mullery Francis William Jr, CEO, ImprimisRx
09 Sep 2025	Form 3: Pollard Randall E., CHIEF ACCOUNTING OFFICER No securities owned
08 Jan 2025	Form 3: Shojaei Amir, CHIEF SCIENTIFIC OFFICER No securities owned
30 Jan 2024	Form 3: Silvernail Lauren P, Director No securities owned
30 Jan 2024	Form 3: Graves Adrienne L, Director No securities owned
08 Apr 2022	Form 3: Sternberg Perry J., Director No securities owned
08 Apr 2022	Form 3: Makary Martin A., Director No securities owned
30 Sep 2020	Form 3: Van Horn R. Lawrence, Director No securities owned
22 May 2020	Form 3: Opaleye Management Inc., 10% owner Holds 2,480,500 shares of Common Stock, $0.001 par value
17 Mar 2020	Form 3: Sparks Teresa, Director No securities owned
13 Nov 2018	Form 3: Imprimis Pharmaceuticals, Inc., 10% owner · Eton Pharmaceuticals Inc Holds 3,500,000 shares of Common Stock
17 Apr 2017	Form 3: Edwards Clayton D, Chief Operating Officer
03 Sep 2015	Form 3: Principi Anthony, Director No securities owned
20 May 2015	Form 3: Opaleye Management Inc., 10% owner Holds 1,167,199 shares of Imprimis Pharmaceuticals, Inc.
20 May 2015	Form 3: Opaleye Management Inc., 10% owner Holds 1,167,199 shares of Imprimis Pharmaceuticals, Inc.
02 Feb 2015	Form 3: Saharek John P., Chief Commercial Officer
09 Jan 2015	Form 3: Lindstrom Richard L Md, Director No securities owned
08 Sep 2014	Form 3: Nelson William H., Director No securities owned
04 Oct 2013	Form 3: Kenny Peter C, Director No securities owned

Comments